Google DeepMind launched AlphaGenome, an AI tool designed to identify genetic drivers of disease.
The system predicts how DNA mutations disrupt gene regulation across different tissues.
AlphaGenome can analyse up to one million DNA letters simultaneously.
Researchers trained the model on large human and mouse genetics databases.
The tool targets mutations linked to cancer, heart disease, autoimmune disorders, and mental illness.
Scientists say it could accelerate drug discovery and gene therapy design.
Experts from University of British Columbia and University College London called it a major advance in genome research.
Google DeepMind Unveils AlphaGenome to Decode Genetic Causes of Disease
Andrew Rogers
Andrew Rogers is a freelance journalist based in the USA, with over 10 years of experience covering Politics, World Affairs, Business, Health, Technology, Finance, Lifestyle, and Culture. He earned his degree in Journalism from the University of Florida. Throughout his career, he has contributed to outlets such as The New York Times, CNN, and Reuters. Known for his clear reporting and in-depth analysis, Andrew delivers accurate and timely news that keeps readers informed on both national and international developments.
Add A Comment
Important Links
Latest News
Outback Gazette delivers trusted news, stories, and insights from Nicosia and beyond. Stay informed with timely updates on business, lifestyle, culture, and community — your daily source for reliable information.
© 2026 Outback Gazette . All Rights Reserved.